SSG Capital Advisors served as the investment banker to Axiom Real-Time Metrics in the sale of substantially all assets to Sitero Canada. The sale was effectuated through a court-supervised receivership proceeding in the Ontario Superior Court of Justice. The transaction closed in July 2025.
Despite a strong operating history and differentiated service offering, Axiom faced macroeconomic pressures, including a decline in new clinical trials across the life sciences sector. In response, the company implemented several initiatives to streamline operations and preserve liquidity in the face of a changing operating environment.
In late 2024, SSG was engaged to advise Axiom through this period of strategic and financial transition. SSG worked closely with management and stakeholders to pursue a range of options, including potential sale and financing solutions. As market conditions evolved and liquidity pressures intensified, SSG executed a highly expedited sale process under a Canadian receivership framework.
Leveraging its expertise in life sciences, technology and special situations, SSG generated significant market engagement and secured multiple indications of interest for the company.
Other professionals who worked on the transaction include:
- Bobby Kofman, Jason Knight and Tony Trifunovic of KSV Restructuring, financial advisor to Axiom’s senior secured creditor and Receiver of the assets, undertakings and properties of Axiom Real-Time Metrics
- Jeffrey Levine and Waël Rostom of McMillan, counsel to Axiom Real-Time Metrics
- Jennifer Stam, Lauren Archibald and Sophie Webb of Norton Rose Fulbright Canada, counsel to Axiom’s senior secured creditor
- George Benchetrit and David Im of Chaitons, counsel to KSV Restructuring
- Stuart Brotman of Fasken Martineau DuMoulin, counsel to Sitero Canada
